Medicines in China’s National Health Insurance System

Discover the intricate landscape of China's healthcare system with Medicines in China’s National Health Insurance System, published by the China Development Research Foundation in 2022. This insightful hardback edition, spanning 64 pages, delves into the selection, procurement, and pricing of medicines within the framework of national health insurance. It provides a comprehensive analysis of reimbursement systems, the prescribing practices, and the usage of drugs in China. Additionally, the book examines the significant role that commercial insurance plays in the financing of medications. Ideal for healthcare professionals, policymakers, and anyone interested in understanding the complexities of China's medical landscape, this book serves as a vital resource for navigating the future of health insurance and pharmaceuticals in one of the world's largest markets.